BRIDG

Biomedical Research Integrated Domain Group (BRIDG) Work Group

• Mission

  Give complete emphasis and support to the future development and global implementation of this domain analysis model into International Data Model of HL7, CDISC and ISO for the support of healthcare and clinical research.

Return to Main Page

• Leadership:
  • CoChairs
    • Edward Helton PhD

    National Cancer Institute

    Term ends Jan 2016

    • Mary Ann Slack

    Food and Drug Administration

    Term ends Jan 2016

BRIDG WG Web Page

ListServ Subscribers: send an e-mail to bridgwg@lists.HL7.org.

Listserv

The BRIDG Listserve is bridg@lists.hl7.org

To subscribe to this service, go to the HL7 Listservices Welcome Page

1. Select Subscribe to List Services
2. Fill in Name, Organization, e-mail and password
3. Select type of mail

Mail 

You receive copies of messages posted to the list as they are delivered and distributed (most common method)

Digest 

Each night, around 12:00 am, you will receive a single email message containing all the messages contributed to the list that day. At the top of the message will be a numbered list of the subjects in that digest, followed by the complete messages themselves. Digest recipients will not receive messages sent to segments.

Digest with Attachments 

The same as a digest, but in MIME format so that the individual messages' formatting is preserved. Some email clients such as Outlook will show the digest as a series of attachments. Digest recipients will not receive messages sent to segments.

1. Scroll down the list to Regulated Clinical Research Information Management
2. Check bridg BRIDG Harmonization
3. Scroll to the bottom of the page and check the confirmation statement
4. Press Request Subscription

You will receive an e-mail confirmation. Follow the instructions on the email to activate your account. Once an account has been confirmed you can mail to the listserv using the mailing address bridg@lists.hl7.org

Information on BRIDG

The BRIDG Model is a collaborative effort of stakeholders from the Clinical Data Interchange Standards Consortium (CDISC), the HL7 Regulated Clinical Research Information Management Technical Committee (RCRIM TC), the National Cancer Institute (NCI), and the US Food and Drug Administration (FDA) to produce a shared view of the dynamic and static semantics that collectively define a shared domain-of-interest, i.e. the domain of clincial and pre-clinical protocol-driven research and its associated regulatory artifacts.

Information on BRIDG can be found at www.bridgmodel.org